drugset / Trial / NCT06441630
A Study to Evaluate the Efficacy and Safety of Co-administration of AD-227A and AD-227B
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of co-administration of AD-227A and AD-227B in patients with essential hypertension
Timeline
- Start
- 2024-07-31
- Primary completion
- 2025-09
- Completion
- 2025-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AD-227A | Unknown | — | Oral |
| Subject | AD-227B | Unknown | — | Oral |
| Comparator | AD-227C | Unknown | — | Oral |